Heat up and Destroy: Immunotherapy of “Cold” Tumors Using the Example of Glioblastoma
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27052457 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Yuliya Nikitina und 8 weiteren Autor:innen. Beteiligte Einrichtung: Scientific Center of Genetics and Life Sciences, Sirius University of Science and Technology, 1 Olimpiysky Avenue, Krasnodar Region, 354340 Sirius, R…. Hauptthemen laut MEDLINE: Glioblastoma, Immunotherapy, Brain Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 330 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The state program of the «Sirius» federal territory, «Scientific and technological development of the «Sirius» Federal Territory», Russian Science Foundation (https://rscf.ru/en/project/24-14-00390/), Scientific Centre of Genetics and Life Sciences at Sirius University of Science and Technology.
Abstract (Originalsprache)
The characterization of tumors as either “hot” or “cold” is determined by intrinsic properties of the cancer cells, the characteristics of the tumor immune landscape, the composition of the tumor microenvironment (TME), and underlying signaling mechanisms. These biological factors are critical in defining the clinical outcomes and therapeutic responses observed in cancer patients. The TME of glioblastoma exemplifies a case of “cold” TME, which significantly hinders antitumor immunity. This constitutes the predominant rationale underlying the ineffectiveness of immunotherapy. This review provides a thorough analysis of contemporary immunotherapeutic strategies that have been developed for the purpose of altering the immunological characteristics of tumors, with a view to achieving their effective elimination. The core mechanisms of action and future clinical applications of immune checkpoint inhibitors, adoptive cellular therapy, and oncolytic viruses (OV) are delineated. A combination of preclinical and clinical evidence suggests that OV-based combinations could be an effective treatment strategy for “cold” tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Scientific Center of Genetics and Life Sciences, Sirius University of Science and Technology, 1 Olimpiysky Avenue, Krasnodar Region, 354340 Sirius, Russia.
- Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of the Russian Academy of Sciences, 8, Akad. Lavrentiev Avenue, 630090 Novosibirsk, Russia.
ORCID-Profile: Maria Bogachek, Anastasia Leonteva, David Sergeevichev, Anna Nushtaeva
Förderung
- The state program of the «Sirius» federal territory, «Scientific and technological development of the «Sirius» Federal Territory»
- Russian Science Foundation (https://rscf.ru/en/project/24-14-00390/)
- Scientific Centre of Genetics and Life Sciences at Sirius University of Science and Technology
Zitieren
APA
Nikitina, Y., Kazakova, A., Bogachek, M., Leonteva, A., Vasileva, N., Sergeevichev, D., Vladimirov, S., Richter, V., & Nushtaeva, A. (2026). Heat up and Destroy: Immunotherapy of “Cold” Tumors Using the Example of Glioblastoma. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27052457
Vancouver
Nikitina Y, Kazakova A, Bogachek M, Leonteva A, Vasileva N, Sergeevichev D, et al. Heat up and Destroy: Immunotherapy of “Cold” Tumors Using the Example of Glioblastoma. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27052457
BibTeX
@article{Nikitina2026,
author = {Nikitina, Yuliya and Kazakova, Alina and Bogachek, Maria and Leonteva, Anastasia and Vasileva, Natalia and Sergeevichev, David and Vladimirov, Sergey and Richter, Vladimir and Nushtaeva, Anna},
title = {Heat up and Destroy: Immunotherapy of “Cold” Tumors Using the Example of Glioblastoma},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27052457}
}
EUVIMED